Concepedia

Ying Li

YL

13

Publications

1.5K

Citations

13

H-Index

2001

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Ying Li is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicinePharmacologyBiochemistryMetabolismPhysiologyCell SignalingDrug DiscoveryCell PhysiologyNatural SciencesMetabolic Syndrome

Publications per year

2001–2019

13

Publications

13

Role of AMP-activated protein kinase in mechanism of metformin action

Gaochao Zhou, Robert P. Myers, Ying Li et al. · Journal of Clinical Investigation · 2001 · 632 citations · Full text

Metformin Action, Cytoskeleton, Cellular Physiology +22

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 329 citations

Cardiac Muscle, Cardiovascular Pharmacology, Glucose Homeostasis +23

Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality

Hua Xu, Melinda C. Aldrich, Qingxia Chen et al. · Journal of the American Medical Informatics Association · 2014 · 229 citations · Full text

ASIC1a regulates insular long-term depression and is required for the extinction of conditioned taste aversion

Wei-Guang Li, Ming-Gang Liu, Shining Deng et al. · Nature Communications · 2016 · 60 citations · Full text

Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers

Timothy A. Blizzard, Frank DiNinno, Jerry D. Morgan et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 58 citations · Full text

Estrogen Receptor Ligands, Dihydrobenzoxathiin Serams, Medicine +8

Rows per page

1–5 of 13